Prevalence of Macrovascular Disease Amongst Type 2 Diabetic Patients Detected by Targeted Screening and Patients Newly Diagnosed in General Practice: the Hoorn Screening Study | AMiner
Prevalence of Macrovascular Disease Amongst Type 2 Diabetic Patients Detected by Targeted Screening and Patients Newly Diagnosed in General Practice: the Hoorn Screening Study
Objectives. Screening for type 2 diabetes has been recommended and targeted screening might be an efficient way to screen. The aim was to investigate whether diabetic patients identified by a targeted screening procedure differ from newly diagnosed diabetic patients in general practice with regard to the prevalence of macrovascular complications.